• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比较美国 18 岁以下儿童中流感和 2019 年冠状病毒病相关住院治疗情况: FluSurv-NET(2017 年 10 月至 2021 年 4 月)和 COVID-NET(2020 年 10 月至 2021 年 9 月)。

Comparison of Influenza and Coronavirus Disease 2019-Associated Hospitalizations Among Children Younger Than 18 Years Old in the United States: FluSurv-NET (October-April 2017-2021) and COVID-NET (October 2020-September 2021).

机构信息

CDC COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

出版信息

Clin Infect Dis. 2023 Feb 8;76(3):e450-e459. doi: 10.1093/cid/ciac388.

DOI:10.1093/cid/ciac388
PMID:35594564
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9129156/
Abstract

BACKGROUND

Influenza virus and SARS-CoV-2 are significant causes of respiratory illness in children.

METHODS

Influenza- and COVID-19-associated hospitalizations among children <18 years old were analyzed from FluSurv-NET and COVID-NET, 2 population-based surveillance systems with similar catchment areas and methodology. The annual COVID-19-associated hospitalization rate per 100 000 during the ongoing COVID-19 pandemic (1 October 2020-30 September 2021) was compared with influenza-associated hospitalization rates during the 2017-2018 through 2019-2020 influenza seasons. In-hospital outcomes, including intensive care unit (ICU) admission and death, were compared.

RESULTS

Among children <18 years, the COVID-19-associated hospitalization rate (48.2) was higher than influenza-associated hospitalization rates: 2017-2018 (33.5), 2018-2019 (33.8), and 2019-2020 (41.7). The COVID-19-associated hospitalization rate was higher among adolescents 12-17 years old (COVID-19: 59.9; influenza range: 12.2-14.1), but similar or lower among children 5-11 (COVID-19: 25.0; influenza range: 24.3-31.7) and 0-4 (COVID-19: 66.8; influenza range: 70.9-91.5) years old. Among children <18 years, a higher proportion with COVID-19 required ICU admission compared with influenza (26.4% vs 21.6%; P < .01). Pediatric deaths were uncommon during both COVID-19- and influenza-associated hospitalizations (0.7% vs 0.5%; P = .28).

CONCLUSIONS

In the setting of extensive mitigation measures during the COVID-19 pandemic, the annual COVID-19-associated hospitalization rate during 2020-2021 was higher among adolescents and similar or lower among children <12 years compared with influenza during the 3 seasons before the COVID-19 pandemic. COVID-19 adds substantially to the existing burden of pediatric hospitalizations and severe outcomes caused by influenza and other respiratory viruses.

摘要

背景

流感病毒和 SARS-CoV-2 是导致儿童呼吸道疾病的重要原因。

方法

对 FluSurv-NET 和 COVID-NET 这两个具有相似集水区和方法的基于人群的监测系统中,年龄<18 岁的儿童因流感和 COVID-19 住院的情况进行了分析。比较了 2020 年 10 月 1 日至 2021 年 9 月 30 日大流行期间 COVID-19 相关住院率(每 10 万人每年)与 2017-2018 年至 2019-2020 年流感季节的流感相关住院率。比较了住院期间的结局,包括入住重症监护病房(ICU)和死亡。

结果

年龄<18 岁的儿童 COVID-19 相关住院率(48.2)高于流感相关住院率:2017-2018 年(33.5)、2018-2019 年(33.8)和 2019-2020 年(41.7)。12-17 岁青少年的 COVID-19 相关住院率较高(COVID-19:59.9;流感范围:12.2-14.1),但 5-11 岁(COVID-19:25.0;流感范围:24.3-31.7)和 0-4 岁(COVID-19:66.8;流感范围:70.9-91.5)儿童的住院率相似或更低。<18 岁的儿童中,COVID-19 住院患者需要 ICU 治疗的比例高于流感(26.4% vs 21.6%;P<.01)。COVID-19 和流感相关住院期间儿科死亡均较为罕见(0.7% vs 0.5%;P=.28)。

结论

在 COVID-19 大流行期间采取广泛缓解措施的情况下,2020-2021 年 COVID-19 相关住院率在青少年中较高,在<12 岁儿童中与 COVID-19 大流行前 3 个季节的流感相似或更低。COVID-19 大大增加了流感和其他呼吸道病毒导致的儿科住院和严重结局的现有负担。

相似文献

1
Comparison of Influenza and Coronavirus Disease 2019-Associated Hospitalizations Among Children Younger Than 18 Years Old in the United States: FluSurv-NET (October-April 2017-2021) and COVID-NET (October 2020-September 2021).比较美国 18 岁以下儿童中流感和 2019 年冠状病毒病相关住院治疗情况: FluSurv-NET(2017 年 10 月至 2021 年 4 月)和 COVID-NET(2020 年 10 月至 2021 年 9 月)。
Clin Infect Dis. 2023 Feb 8;76(3):e450-e459. doi: 10.1093/cid/ciac388.
2
Hospitalization of Adolescents Aged 12-17 Years with Laboratory-Confirmed COVID-19 - COVID-NET, 14 States, March 1, 2020-April 24, 2021.12-17 岁青少年因实验室确诊 COVID-19 住院情况 - COVID-NET,14 个州,2020 年 3 月 1 日-2021 年 4 月 24 日。
MMWR Morb Mortal Wkly Rep. 2021 Jun 11;70(23):851-857. doi: 10.15585/mmwr.mm7023e1.
3
Rates of Influenza-Associated Hospitalization, Intensive Care Unit Admission, and In-Hospital Death by Race and Ethnicity in the United States From 2009 to 2019.2009 年至 2019 年美国按种族和族裔划分的流感相关住院率、重症监护病房入院率和住院死亡率。
JAMA Netw Open. 2021 Aug 2;4(8):e2121880. doi: 10.1001/jamanetworkopen.2021.21880.
4
Prevalence of SARS-CoV-2 and Influenza Coinfection and Clinical Characteristics Among Children and Adolescents Aged <18 Years Who Were Hospitalized or Died with Influenza - United States, 2021-22 Influenza Season.2021-2022 年流感季美国因流感住院或死亡的<18 岁以下儿童和青少年中 SARS-CoV-2 和流感合并感染的流行率及临床特征。
MMWR Morb Mortal Wkly Rep. 2022 Dec 16;71(50):1589-1596. doi: 10.15585/mmwr.mm7150a4.
5
Hospitalizations Associated with COVID-19 Among Children and Adolescents - COVID-NET, 14 States, March 1, 2020-August 14, 2021.儿童和青少年因 COVID-19 住院情况 - COVID-NET,14 个州,2020 年 3 月 1 日至 2021 年 8 月 14 日。
MMWR Morb Mortal Wkly Rep. 2021 Sep 10;70(36):1255-1260. doi: 10.15585/mmwr.mm7036e2.
6
High Influenza Incidence and Disease Severity Among Children and Adolescents Aged <18 Years - United States, 2022-23 Season.高流感发病率和疾病严重程度在儿童和青少年<18 岁-美国,2022-23 季节。
MMWR Morb Mortal Wkly Rep. 2023 Oct 13;72(41):1108-1114. doi: 10.15585/mmwr.mm7241a2.
7
Hospitalization Rates and Characteristics of Children Aged <18 Years Hospitalized with Laboratory-Confirmed COVID-19 - COVID-NET, 14 States, March 1-July 25, 2020.**儿童**:<18 岁,**实验室确诊** COVID-19 住院率及特征——COVID-NET,14 个州,2020 年 3 月 1 日-7 月 25 日。
MMWR Morb Mortal Wkly Rep. 2020 Aug 14;69(32):1081-1088. doi: 10.15585/mmwr.mm6932e3.
8
Estimating influenza disease burden from population-based surveillance data in the United States.根据美国基于人群的监测数据估算流感疾病负担。
PLoS One. 2015 Mar 4;10(3):e0118369. doi: 10.1371/journal.pone.0118369. eCollection 2015.
9
Comparison of Clinical Features of COVID-19 vs Seasonal Influenza A and B in US Children.美国儿童中 COVID-19 与季节性流感 A 型和 B 型的临床特征比较。
JAMA Netw Open. 2020 Sep 1;3(9):e2020495. doi: 10.1001/jamanetworkopen.2020.20495.
10
Influenza-associated hospitalizations in the United States.美国与流感相关的住院情况。
JAMA. 2004 Sep 15;292(11):1333-40. doi: 10.1001/jama.292.11.1333.

引用本文的文献

1
Short and long-term outcomes of children and adolescents hospitalized with COVID-19 or influenza: results of the AUTCOV study.因新冠病毒病或流感住院的儿童和青少年的短期和长期结局:AUTCOV研究结果
Sci Rep. 2025 Jul 2;15(1):22692. doi: 10.1038/s41598-025-07360-4.
2
Clinical and Paraclinical Peculiarities of SARS-CoV-2 and Influenza Infections in Children: A Comparative Study.儿童感染新型冠状病毒和流感的临床及辅助检查特点:一项对比研究
Life (Basel). 2025 May 14;15(5):784. doi: 10.3390/life15050784.
3
Evaluation of Cellular Immune Responses After mRNA-1273 Vaccination in Children 6 Months to 11 Years of Age.6个月至11岁儿童接种mRNA-1273疫苗后细胞免疫反应的评估。
J Infect Dis. 2025 Jun 2;231(5):e945-e955. doi: 10.1093/infdis/jiaf144.
4
Severity, outcomes, and vaccination status in hospitalized children who tested positive for SARS-CoV-2 during two pandemic waves.两波疫情期间新冠病毒检测呈阳性的住院儿童的病情严重程度、预后及疫苗接种状况
Med Pharm Rep. 2025 Jan;98(1):54-59. doi: 10.15386/mpr-2850. Epub 2025 Jan 31.
5
Burden of Illness Associated With Respiratory Syncytial Virus, Influenza, and Coronavirus Disease 2019 in Infants and Young Children in Ontario, Canada, 2018-2023: A Population-Based Canadian Immunization Research Network Study.2018 - 2023年加拿大安大略省婴幼儿呼吸道合胞病毒、流感和2019冠状病毒病相关疾病负担:一项基于人群的加拿大免疫研究网络研究
Open Forum Infect Dis. 2024 Oct 8;11(10):ofae601. doi: 10.1093/ofid/ofae601. eCollection 2024 Oct.
6
Risk of COVID-19 in Children throughout the Pandemic and the Role of Vaccination: A Narrative Review.新冠大流行期间儿童感染新冠病毒的风险及疫苗接种的作用:一项叙述性综述
Vaccines (Basel). 2024 Aug 29;12(9):989. doi: 10.3390/vaccines12090989.
7
Safety and Immunogenicity of an mRNA-1273 Booster in Children.儿童mRNA-1273加强针的安全性和免疫原性
Clin Infect Dis. 2024 Dec 17;79(6):1524-1532. doi: 10.1093/cid/ciae420.
8
Safety and durability of mRNA-1273-induced SARS-CoV-2 immune responses in adolescents: results from the phase 2/3 TeenCOVE trial.mRNA-1273诱导的SARS-CoV-2免疫反应在青少年中的安全性和持久性:2/3期青少年COVE试验结果
EClinicalMedicine. 2024 Jul 18;74:102720. doi: 10.1016/j.eclinm.2024.102720. eCollection 2024 Aug.
9
Clinical Manifestations Laboratory Tests Abdominal Ultrasonic Findings and In-hospital Prognosis of COVID-19 in 185 Pediatric Cases in a Tertiary Center.三级中心185例儿童COVID-19的临床表现、实验室检查、腹部超声检查结果及院内预后
Arch Iran Med. 2023 Dec 1;26(12):679-687. doi: 10.34172/aim.2023.100.
10
Severe pediatric COVID-19: a review from the clinical and immunopathophysiological perspectives.严重儿童 COVID-19:从临床和免疫病理生理学角度的综述。
World J Pediatr. 2024 Apr;20(4):307-324. doi: 10.1007/s12519-023-00790-y. Epub 2024 Feb 6.